USE OF LOW-MOLECULAR-WEIGHT HEPARIN IN POSTANGIOPLASTY MANAGEMENT

The results of using low molecular weight heparin (LMWH) in postangiop lasty management are examined. In comparison to intravenous unfraction ated heparin, subcutaneous LMWH caused less groin complications and wa s simpler and cheaper to be administered by the medical personnel. The incidence of ischaemic complications after angioplasty including acut e closure and myocardial infarction, however, remained similar and was not excessive. Subcutaneous administration of LMWH provides an altern ative simple and cost-effective strategy for postangioplasty managemen t. Copyright (C) 1997 Elsevier Science Ireland Ltd.